In this study, we therefore aimed to investigate the effect of 8 weeks of mono‐treatment with an aldosterone receptor antagonist (MR blockade) on endothelial function, tissue perfusion and ROS signaling in individuals with type 2 diabetes compared to healthy controls. The gene discussed is NR3C2; the disease is type 2 diabetes mellitus.